title: [Effects of marinobufagenin on electrophysiological and contractile characteristics of the rat diaphragm].
abstract: Effects of Na+,K(+)-ATPase inhibitor: marinobufagenin, on contractile and electric characteristics of isolated rat diaphragm were studied for the first time. Marinobufagenin induced dose-dependent (EC50 = 0.3 +/- 0.1 nM) increase in the contraction force (positive inotropic effect). At 1-2 nM, it slowed down the fatigue induced by continuous direct stimulation (2/s) of the muscle. Marinobufagenin at the same concentrations did not affect resting membrane potential or parameters of action potentials of muscle fibers, while at 10 and 20 nM it induced hyperpolarization by approximately 2 mV. Marinobufagenin blocked dose-dependently (IC50 = 2.9 +/- 2.0 nM) hyperpolarizing effect of acetylcholine (100 nM) mediated by increase in electrogenic contribution of alpha2 isoform of the Na+,K(+)-ATPase. This result suggests a capability of marinobufagenin to inhibit this isoform of the Na+,K(+)-ATPase. Possible mechanisms of marinobufagenin effects in skeletal muscle are discussed.
authors.forename: I I
authors.initials: II
authors.lastname: Krivoĭ
authors.forename: V V
authors.initials: VV
authors.lastname: Kravtsova
authors.forename: A V
authors.initials: AV
authors.lastname: Prokof'ev
authors.forename: E V
authors.initials: EV
authors.lastname: Vashchinkina
authors.forename: I V
authors.initials: IV
authors.lastname: Kubasov
authors.forename: T M
authors.initials: TM
authors.lastname: Drabkina
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D002018:Bufanolides / Q000378:metabolism / Q000494:pharmacology*; D003964:Diaphragm / Q000187:drug effects / Q000502:physiology; D066298:In Vitro Techniques; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects*; D020033:Protein Isoforms / Q000037:antagonists & inhibitors / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000502:physiology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
chemical_list: D002018:Bufanolides; D020033:Protein Isoforms; D014662:Vasoconstrictor Agents; C093896:marinobufagenin; D000254:Sodium-Potassium-Exchanging ATPase; D000109:Acetylcholine